Phase I/II clinical trial demonstrates safety and tolerability of GVAX lung cancer vaccine Sep. 15, 2000 No Comments
Novel duocarmycin derivative suitable for use in anticancer immunoconjugates Sep. 15, 2000 No Comments
StressGen commences phase II trial of HspE7 for treatment of cervical cancer Sep. 12, 2000 No Comments
Herceptin approved in E.U. for treatment of HER2-positive metastatic breast cancer Aug. 30, 2000 No Comments
LifeTime Pharmaceuticals announces U.S. phase I/II trials of Beta LT for cancer Aug. 29, 2000 No Comments
RSS